Navigation Links
TriMix Laboratories Announces New Partnership With American Pharmacy Solutions
Date:8/5/2008

CHERRY HILL, N.J., Aug. 5 /PRNewswire/ -- TriMix Laboratories LLC today announced it has entered into an agreement with American Pharmacy Solutions as the exclusive pharmacy for prescription fulfillment of TriMix gel(TM). TriMix gel(TM) has been prescribed by doctors as a first line and secondary treatment for erectile dysfunction (ED). American Pharmacy Solutions (APS) is a licensed compounding pharmacy which makes TriMix gel(TM) medicine for each individual patient in response to a prescription from a physician. For more information on TriMix gel(TM), visit http://www.trimixgel.com .

APS Owner and President Steve Berklow states, "Our 50 years of experience in the pharmacy industry leaves us uniquely qualified to enter into this relationship with TriMix Laboratories. We look forward to delivering top shelf quality service and medicine to our patients."

T.J. Harkins, President of TriMix Laboratories commented, "We are happy to have APS on board with us. They are a first class operation and they will undoubtedly make a positive reflection on us and become an important part of our patients' health care regimen with TriMix gel(TM) and the other quality products they provide."

TriMix gel(TM) is a gel-based treatment which has been prescribed for ED patients who have failed on Viagra(R), Levitra(R) and Cialis(R) type tablets or who could not tolerate the side effects. It uses an all-in-one ED gel(TM) Application System (pat. pend.) which stores, mixes and applies the medicine at time of use. One feature of this methodology of medicine delivery is that the medicine in this form does not have to be refrigerated and can be carried by the patient at room temperature. Additionally, TriMix gel(TM) uses FDA approved vasodilation components but does not have to be self injected with a needle because it is classified as a topical gel.

TriMix gel contains active ingredients which are classified as medicine and are listed in the US Pharmacopeia. Therefore, a patient would need a prescription from his physician to obtain TriMix gel. For an order form for your doctor, visit http://www.trimixgel.com and click the prescription form. Give the form to your doctor. He can fax a prescription to American Pharmacy Solutions at 877-387-4649 and the pharmacy will ship the medicine directly to the patient.

Recently, clinical trials were performed on TriMix gel(TM). All the test patients were men who had failed on Viagra(R), Levitra(R) or Cialis(R). These patients were given TriMix gel(TM). All the test patients received some degree of positive effect from TriMix gel(TM). It was determined that 40% of the test patients achieved a result sufficient for sexual intercourse over Viagra(R), Levitra(R) or Cialis(R) tablets. For more information visit the web at http://trimixgel.com/studies.html .

The profession of pharmacy has always been based on the patient-physician-pharmacist relationship, known as the "Triad." Through this "Triad" relationship, patient needs are determined by a physician, who chooses a treatment regimen that may include a compounded medication. Physicians often prescribe compounded medications for various reasons, such as when a patient cannot ingest a medication in its available form. A pharmacist can prepare the medication in cream, liquid, gel or any other form that the patient can more easily take.

TriMix Laboratories LLC is a medical research and marketing firm specializing in the urological subspecialty of erectile dysfunction. American Pharmacy Solutions is a recognized leader in pharmaceutical compounding, helping Physicians and Veterinarians with medicine precisely customized for each individual patient. American Pharmacy maintains federal and state licenses and permits and is registered to dispense in almost all states. For more information, visit http://www.TriMix-gel.com .

This press release contains forward-looking statements. These statements involve risks and uncertainties which may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed and actual results may differ materially. Ingredients in TriMix gel(TM) are FDA approved but TriMix gel(TM) is a custom compound made in a pharmacy and therefore has not been approved by the FDA for treatment of ED. TriMix gel(TM) requires a valid prescription from a physician. You should discuss the risks and side effects associated with this drug with your physician. Before taking any action, consult your physician.

Contact:

T.J. Harkins

TriMix Laboratories

Cherry Hill, NJ

856-428-7008


'/>"/>
SOURCE TriMix Laboratories LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Codexis Appoints Singapore Laboratories Managing Director
2. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
3. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
4. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
5. Stiefel Laboratories Appoints Two New Members to Board of Directors
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg
7. ARUP Laboratories Releases ARUP Consult(R) 2.0
8. Forest Laboratories Lexapro and Generics-Dominated Fluoxetine Lead First-Line Therapy in the Treatment for Major Depression
9. Carrington Laboratories Common Stock Now Trading on the OTC Bulletin Board: CARN.OB
10. Free White Paper Helps Biotech Laboratories Maintain a High Level of Infection Control
11. Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
Breaking Biology Technology:
(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:6/1/2016)... -- Favorable Government Initiatives Coupled With Implementation ... to Boost Global Biometrics System Market Through 2021  ... " Global Biometrics Market By Type, By End ... - 2021", the global biometrics market is projected to ... growing security concerns across various end use sectors such ...
Breaking Biology News(10 mins):